TrialJAMA oncology2017

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.

Manish A Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.